Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

September 23, 2022

81% Survival at 30 Days in a Multi-Center, Multi-Society Study of Impella®-Supported AMICS Patients in Japan

Junya Ako, MD, presents outcomes in AMI cardiogenic shock from Japan's J-PVAD study at TCT 2022.

September 16, 2022

TCT 2022: Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Jonathan Hill, MD, discusses influential trials in high-risk PCI that are shaping the future of ischemic heart failure therapy.

September 16, 2022

TCT 2022: Data Integrity in Real-World Evidence

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

August 26, 2022

Case Study Epitomizing Results from RESTORE EF  

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.

August 15, 2022

RESTORE EF: Ejection Fraction Improvement with Complete Revascularization

Mitul Patel, MD, discusses the RESTORE EF study and a successful case of improved ejection fraction with complete revascularization.

August 15, 2022

RESTORE EF Case Study: Contemporary Practices for Impella®-Supported Complete Revascularization

Jason Wollmuth, MD, describes best practice techniques for Impella-supported complete revascularization in a RESTORE EF case.

August 12, 2022

NCSI to RECOVER IV  

Babar Basir, MD, highlights key concepts in the NCSI protocol that will be studied in the RECOVER IV randomized controlled trial.

August 11, 2022

Moving the Needle in AMI Cardiogenic Shock Survival

William O’Neill, MD, discusses the need for designing programs to improve outcomes in patients with AMI cardiogenic shock.

August 10, 2022

First PROTECT IV Patient Case in California

Aditya Bharadwaj, MD, walks through the first PROTECT IV case enrolled at Loma Linda University Health Care in California.

July 7, 2022

Factoring Hemodynamics into Decisions for Use of MCS During High-Risk PCI  

Babar Basir, MD, discusses how hemodynamics can help clinicians decide whether to use mechanical circulatory support (MCS) in patients undergoing high-risk PCI.

July 1, 2022

Excellent High-risk PCI Outcomes in a Community Setting  

Mihas Kodenchery, MD, and Laura Rodriguez, NP, discuss the low mortality and low complication rates in their high-volume high-risk PCI practice.
 

June 30, 2022

 The Current State of MCS for AMICS  

William O’Neill, MD, discusses the current state of mechanical circulatory support for AMI cardiogenic shock.
 

June 22, 2022

Postpartum Myocarditis Escalated to Impella 5.5® with SmartAssist®  

This case study describes how escalation of support to Impella 5.5 with SmartAssist enabled heart recovery in a 33-year-old woman with postpartum myocarditis.
 

June 21, 2022

Optimizing AMICS Patient Care Prior to Leaving the Cath Lab

Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.

June 21, 2022

Data Integrity in Real-World Evidence

Bobby Yeh, MD, discusses how real-world evidence factors into treatment decisions made every day in clinical practice.

NPS-1674